Stephane Peluso - 02 Aug 2021 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Chief Scientific Officer
Signature
/s/Stephane Peluso
Issuer symbol
N/A
Transactions as of
02 Aug 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 08:01:29 UTC
Next filing
12 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Options (right to buy) Award $0 +250,000 $0.000000 250,000 02 Aug 2021 Common Stock 250,000 $2.93 Direct F1
transaction INFI Restricted Stock Unit Award $0 +50,000 $0.000000 50,000 02 Aug 2021 Common Stock 50,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 12/48th of the shares on August 2, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter, provided that the Reporting Person continues to serve as the issuer's Chief Scientific Officer on each vesting date.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer's common stock.
F3 Subject to the Reporting Person's continued employment as the Chief Scientific Officer of the issuer, the RSUs will vest as to all 50,000 shares of common stock on August 2, 2022.